This HTML5 document contains 118 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n12https://web.archive.org/web/20170322220917/https:/www.bms.com/about-us/
yago-reshttp://yago-knowledge.org/resource/
dbohttp://dbpedia.org/ontology/
foafhttp://xmlns.com/foaf/0.1/
n24http://appft1.uspto.gov/netacgi/
n18http://v3.espacenet.com/
n25http://www.zymogenetics.com/
n22https://global.dbpedia.org/id/
yagohttp://dbpedia.org/class/yago/
schemahttp://schema.org/
dbthttp://dbpedia.org/resource/Template:
rdfshttp://www.w3.org/2000/01/rdf-schema#
n11http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#
freebasehttp://rdf.freebase.com/ns/
n27https://web.archive.org/web/20170322220917/https://www.bms.com/about-us/
n17http://viaf.org/viaf/
n14http://commons.wikimedia.org/wiki/Special:FilePath/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
wikipedia-enhttp://en.wikipedia.org/wiki/
dbchttp://dbpedia.org/resource/Category:
dbphttp://dbpedia.org/property/
provhttp://www.w3.org/ns/prov#
xsdhhttp://www.w3.org/2001/XMLSchema#
wikidatahttp://www.wikidata.org/entity/
goldhttp://purl.org/linguistics/gold/
dbrhttp://dbpedia.org/resource/

Statements

Subject Item
dbr:ZymoGenetics
rdf:type
wikidata:Q4830453 yago:SocialGroup107950920 wikidata:Q43229 dbo:Agent n11:SocialPerson n11:Agent dbo:Organisation yago:Abstraction100002137 yago:WikicatCompaniesBasedInSeattle,Washington wikidata:Q24229398 yago:WikicatBiotechnologyCompaniesOfTheUnitedStates yago:Organization108008335 yago:YagoPermanentlyLocatedEntity yago:YagoLegalActor yago:YagoLegalActorGeo owl:Thing yago:Group100031264 yago:WikicatCompaniesEstablishedIn1981 yago:Company108058098 schema:Organization dbo:Company yago:Institution108053576
rdfs:label
ZymoGenetics
rdfs:comment
ZymoGenetics, Inc was one of the oldest biotechnology/pharmaceutical companies in the USA, based in Seattle, Washington. The company was involved in the development of therapeutic proteins. Located on Lake Union, the address of the ZymoGenetics headquarters was 1201 Eastlake Avenue East. It was closed in 2019 after its acquisition by Bristol Myers Squibb.
foaf:name
ZymoGenetics
foaf:homepage
n12:our-company.html n27:our-company.html
dbp:name
ZymoGenetics
foaf:depiction
n14:ZymogeneticsAsViewedFromLakeUnion.jpg n14:Logo_of_Company_ZymoGenetics.jpg
dcterms:subject
dbc:Health_care_companies_based_in_Washington_(state) dbc:Pharmaceutical_companies_established_in_1981 dbc:Companies_based_in_Seattle dbc:2010_mergers_and_acquisitions dbc:1981_establishments_in_Washington_(state) dbc:Biotechnology_companies_of_the_United_States dbc:Bristol_Myers_Squibb dbc:American_companies_established_in_1981 dbc:Pharmaceutical_companies_disestablished_in_2010
dbo:wikiPageID
737761
dbo:wikiPageRevisionID
1092789644
dbo:wikiPageWikiLink
dbr:University_of_British_Columbia dbc:Health_care_companies_based_in_Washington_(state) dbr:Recombinant_proteins dbr:Fred_Hutchinson_Cancer_Research_Center dbr:Novo_Nordisk dbr:President_(corporate_title) dbr:Pharmaceutical dbc:Companies_based_in_Seattle dbc:Pharmaceutical_companies_established_in_1981 dbc:2010_mergers_and_acquisitions dbr:University_of_Washington dbr:Seattle_Genetics dbr:Lake_Union dbr:Nobel_Prize_in_Chemistry dbr:Michael_Smith_(chemist) dbr:Seattle_City_Light dbc:1981_establishments_in_Washington_(state) dbr:Protein dbr:Washington_(state) dbr:Chief_executive_officer dbc:Biotechnology_companies_of_the_United_States dbc:Bristol_Myers_Squibb dbr:Denmark dbc:American_companies_established_in_1981 dbr:Seattle dbr:Biotechnology dbc:Pharmaceutical_companies_disestablished_in_2010 dbr:Public_utility dbr:Bristol-Myers_Squibb dbr:Bothell,_Washington dbr:Earl_Davie
dbo:wikiPageExternalLink
n12:our-company.html n18:results%3FIA=ZymoGenetics&sf=q&FIRST=1&CY=gb&LG=en&DB=EPODOC&st=IA&kw=ZymoGenetics&Submit=SEARCH&=&=&=&=&= n24:nph-Parser%3FSect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=0&f=S&l=50&TERM1=ZymoGenetics&FIELD1=&co1=AND&TERM2=&FIELD2=&d=PG01 n25:
owl:sameAs
yago-res:ZymoGenetics n17:131692889 freebase:m.0372cd n22:4xbtj wikidata:Q8075922
dbp:wikiPageUsesTemplate
dbt:Reflist dbt:Infobox_company dbt:Portal dbt:Start_date_and_age dbt:Med-company-stub dbt:Short_description dbt:Authority_control
dbo:thumbnail
n14:Logo_of_Company_ZymoGenetics.jpg?width=300
dbp:founded
in Seattle, Washington
dbp:founders
Earl W. Davie, Michael Smith and Benjamin D. Hall
dbp:homepage
n12:our-company.html
dbp:hqLocation
Lake Union Steam Plant Building
dbp:hqLocationCity
1201
dbp:hqLocationCountry
Washington, USA
dbp:imageCaption
Zymogenetics headquarters, as viewed from Lake Union in Seattle, Washington
dbp:imageSize
225
dbp:industry
Biotechnology/Pharmaceuticals
dbp:keyPeople
Stephanie Feldt
dbp:logo
Logo_of_Company_ZymoGenetics.jpg
dbp:logoSize
200
dbp:owner
dbr:Bristol-Myers_Squibb
dbp:products
Pharmaceuticals
dbp:type
Public
dbo:abstract
ZymoGenetics, Inc was one of the oldest biotechnology/pharmaceutical companies in the USA, based in Seattle, Washington. The company was involved in the development of therapeutic proteins. Located on Lake Union, the address of the ZymoGenetics headquarters was 1201 Eastlake Avenue East. It was closed in 2019 after its acquisition by Bristol Myers Squibb. The company was founded in 1981 by Professors Earl W. Davie and Benjamin D. Hall of the University of Washington and 1993 Nobel Laureate in Chemistry Michael Smith of the University of British Columbia. Soon after its founding, ZymoGenetics began working on recombinant proteins with Danish company Novo Nordisk, and was acquired by that company in 1988. It was spun off as a public company in 2000. Bristol-Myers Squibb acquired the company in 2010 for $885 million. ZymoGenetics' headquarters was previously in the landmark Lake Union Steam Plant building. This structure was built from 1914 to 1921 by Seattle City Light, the municipal electric utility. At the time, the building was in poor condition with many broken windows; Bruce Carter, the chief executive at the time, described it as "the mother of all fixer-uppers". In December 2016, ZymoGenetics announced that they would not renew the lease to the Steam Plant building, due to expire in 2019; the Fred Hutchinson Cancer Research Center later moved into it. At the time, ZymoGenetics did not plan on closing its Bothell manufacturing site; however, it was sold to Seattle Genetics in August 2017. ZymoGenetics closed completely in 2019.
gold:hypernym
dbr:Companies
schema:sameAs
n17:131692889
prov:wasDerivedFrom
wikipedia-en:ZymoGenetics?oldid=1092789644&ns=0
dbo:wikiPageLength
12128
dbo:foundingYear
1981-01-01
dbo:foundedBy
dbr:Earl_Davie dbr:Michael_Smith_(chemist)
dbo:industry
dbr:Biotechnology
dbo:locationCity
dbr:Seattle
dbo:locationCountry
dbr:Washington_(state)
dbo:owner
dbr:Bristol-Myers_Squibb
dbo:owningCompany
dbr:Bristol-Myers_Squibb
foaf:isPrimaryTopicOf
wikipedia-en:ZymoGenetics